Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Perceptual-cognitive three-dimensional multiple-object tracking task can help the monitoring of sport-related concussion.

Chermann JF, Romeas T, Marty F, Faubert J.

BMJ Open Sport Exerc Med. 2018 Oct 1;4(1):e000384. doi: 10.1136/bmjsem-2018-000384. eCollection 2018.

2.

Return to rugby after brain concussion: a prospective study in 35 high level rugby players.

Chermann JF, Klouche S, Savigny A, Lefevre N, Herman S, Bohu Y.

Asian J Sports Med. 2014 Dec;5(4):e24042. doi: 10.5812/asjsm.24042. Epub 2014 Nov 1.

3.

Antiviral activities of sulfated polysaccharides isolated from Sphaerococcus coronopifolius (Rhodophytha, Gigartinales) and Boergeseniella thuyoides (Rhodophyta, Ceramiales).

Bouhlal R, Haslin C, Chermann JC, Colliec-Jouault S, Sinquin C, Simon G, Cerantola S, Riadi H, Bourgougnon N.

Mar Drugs. 2011;9(7):1187-209. doi: 10.3390/md9071187. Epub 2011 Jul 6.

4.

Klüver Bucy syndrome, unusual consequence of excessively rapid correction of severe hyponatremia.

Tuleja E, Chermann JF, Séréni C, Hart G, Séréni D.

Presse Med. 2008 Jun;37(6 Pt 1):975-7. doi: 10.1016/j.lpm.2007.08.021. Epub 2008 Mar 28.

5.

A recombinant human monoclonal anti-R7V antibody as a potential therapy for HIV infected patients in failure of HAART.

Haslin C, Lévêque M, Ozil A, Cérutti P, Chardès T, Chermann JC, Duonor-Cérutti M.

Hum Antibodies. 2007;16(3-4):73-85.

PMID:
18334743
6.

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983.

Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L.

Rev Invest Clin. 2004 Mar-Apr;56(2):126-9. No abstract available.

PMID:
15378805
7.

[Preliminary investigation on the relation between clinical progress and anti-small monomolecular peptides antibody in individual infected with HIV].

Xu X, Xing H, Gong W, Chen H, Si C, Wang Y, Chermann JC.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002 Sep;16(3):286-7. Chinese.

PMID:
12665943
8.

Anti-R7V antibodies as therapeutics for HIV-infected patients in failure of HAART.

Haslin C, Chermann JC.

Curr Opin Biotechnol. 2002 Dec;13(6):621-4. Review.

PMID:
12482524
9.

Synthesis and antiviral activity of new anti-HIV amprenavir bioisosteres.

Rocheblave L, Bihel F, De Michelis C, Priem G, Courcambeck J, Bonnet B, Chermann JC, Kraus JL.

J Med Chem. 2002 Jul 18;45(15):3321-4.

PMID:
12109915
10.

A brief reflection on the development of human retrovirology: the past, the present and the future.

Chermann JC.

J Hum Virol. 2001 Nov-Dec;4(6):289-95. Review. No abstract available.

PMID:
12082395
11.

[Anatomy and basic knowledge of the spinal cord].

Chermann JF.

Rev Prat. 2001 Jun;51(11):1176-9. French.

PMID:
11503485
12.

[Research of status of provirus HIV DNA in non-progressor and progressor of HIV-1 infected persons].

Xu X, Chen L, Wang Q, Chermann JC.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2000 Dec;14(4):333-7.

PMID:
11471019
14.

Synthesis and anti-HIV activity of alpha-thiophenoxy-hydroxyethylamide derivatives.

Medou M, Priem G, Rocheblave L, Pepe G, Meyer M, Chermann JC, Kraus JL.

Eur J Med Chem. 1999 Jul-Aug;34(7-8):625-38.

PMID:
11278047
15.

New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation.

Vlieghe P, Bihel F, Clerc T, Pannecouque C, Witvrouw M, De Clercq E, Salles JP, Chermann JC, Kraus JL.

J Med Chem. 2001 Mar 1;44(5):777-86.

PMID:
11262088
16.

Synthesis and anti-HIV evaluation of new 2',3'-dideoxy-3'-thiacytidine prodrugs.

Mourier N, Camplo M, Della Bruna GS, Pellacini F, Ungheri D, Chermann JC, Kraus JL.

Nucleosides Nucleotides Nucleic Acids. 2000 Jul;19(7):1057-91.

PMID:
10999248
17.

Use of proline bioisosteres in potential HIV protease inhibitors: phenylalanine-2-thiophenoxy-3-pyrrolidinone: synthesis and anti-HIV evaluation.

Kraus JL, Bouygues M, Courcambeck J, Chermann JC.

Bioorg Med Chem Lett. 2000 Sep 4;10(17):2023-6.

PMID:
10987441
18.

New anti-HIV derivatives: synthesis and antiviral evaluation.

De Michelis C, Rocheblave L, Priem G, Chermann JC, Kraus JL.

Bioorg Med Chem. 2000 Jun;8(6):1253-62.

PMID:
10896105
19.
20.

Antiviral and anticoagulant activities of a water-soluble fraction of the marine diatom Haslea ostrearia.

Bergé JP, Bourgougnon N, Alban S, Pojer F, Billaudel S, Chermann JC, Robert JM, Franz G.

Planta Med. 1999 Oct;65(7):604-9.

PMID:
10575374
21.

New polyazamacrocycle-nucleoside conjugates: synthesis, anti-HIV evaluation and interaction with CXCR-4 coreceptor.

Dessolin J, Galéa P, Vlieghe P, Chermann JC, Kraus JL.

Nucleosides Nucleotides. 1999 Apr-May;18(4-5):881-2.

PMID:
10432701
22.

Synthesis and biological evaluation of polyaminated 2',3'-dideoxy-3'-thiacytidine prodrugs.

Camplo M, Mourier N, Chermann JC, Kraus JL.

Nucleosides Nucleotides. 1999 Apr-May;18(4-5):879-80.

PMID:
10432700
23.

Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity.

Klein JL, Roberts JD, George MD, Kurtzberg J, Breton P, Chermann JC, Olden K.

Br J Cancer. 1999 Apr;80(1-2):87-95.

24.

HIV as the cause of AIDS and associated diseases.

Galéa P, Chermann JC.

Genetica. 1998;104(2):133-42. Review.

PMID:
10220906
25.
26.

Role of Kaposi's sarcoma cells in recruitment of circulating leukocytes: implications in pathogenesis.

Galea P, Frances V, Dou-Dameche L, Sampol J, Chermann JC.

J Hum Virol. 1998 May-Jun;1(4):273-81.

PMID:
10195252
27.
28.

Rationale for a vaccine using cellular-derived epitope presented by HIV isolates.

Galéa P, le Contel C, Coutton C, Chermann JC.

Vaccine. 1999 Mar 26;17(13-14):1700-5. Review.

PMID:
10194825
29.

New bicyclam-AZT conjugates: design, synthesis, anti-HIV evaluation, and their interaction with CXCR-4 coreceptor.

Dessolin J, Galea P, Vlieghe P, Chermann JC, Kraus JL.

J Med Chem. 1999 Jan 28;42(2):229-41.

PMID:
9925728
30.

Design, synthesis and structure relationships of new N,N',N",N"'-tetrakis (omega-amino alkyl) tetraazamacrocycles.

Trabaud C, Dessolin J, Camplo M, Hantz O, Zoulim F, Borel C, Meyer M, Pepe G, Chermann JC, Kraus JL.

Antivir Chem Chemother. 1998 Jan;9(1):73-84.

PMID:
9875379
31.

Synthesis and anti-HIV activities of symmetrical N1,N3-dibenzyl-2-hydroxy-propane derivatives.

Medou M, Bouygues M, Rocheblave L, Chermann JC, Kraus JL.

Bioorg Med Chem Lett. 1998 Jul 21;8(14):1861-6.

PMID:
9873448
32.

Syntheses of new modified Phe-Pro peptides. Use of proline replacements in potential HIV inhibitors.

Bouygues M, Medou M, Quéléver G, Chermann JC, Camplo M, Kraus JL.

Bioorg Med Chem Lett. 1998 Feb 3;8(3):277-80.

PMID:
9871669
33.

Primary intestinal epithelial cells can be infected with laboratory-adapted strain HIV type 1 NDK but not with clinical primary isolates.

Chenine AL, Matouskova E, Sanchez G, Reischig J, Pavlikova L, LeContel C, Chermann JC, Hirsch I.

AIDS Res Hum Retroviruses. 1998 Sep 20;14(14):1235-8.

PMID:
9764906
34.

Sexual and mother-to-child transmission of the human immunodeficiency virus type 1: a review.

Chermann JC.

Am J Reprod Immunol. 1998 Sep;40(3):183-6. Review.

PMID:
9764363
35.

Tri-N-Boc-tetraazamacrocycle-nucleoside conjugates: synthesis and anti-HIV activities.

Dessolin J, Vlieghe P, Bouygues M, Medou M, Quéléver G, Camplo M, Chermann JC, Kraus JL.

Nucleosides Nucleotides. 1998 May;17(5):957-68.

PMID:
9708333
36.

Neutralizing antibodies in Brazilian sera against three strains of human immunodeficiency virus type 1 (HIV-1).

Machado AA, Hirsch I, Figueiredo JF, Martinez R, Chermann JC.

Rev Inst Med Trop Sao Paulo. 1997 Nov-Dec;39(6):319-22.

PMID:
9674281
37.

Apoptosis of CD4+ T cells induced after contact with HIV1-infected or non-infected macrophages.

Godard CM, Serriès H, Fulachier C, Chermann JC.

Res Virol. 1997 Nov-Dec;148(6):383-96.

PMID:
9498010
38.

[HIV virus detection in ejaculates collected at different times in seropositive patients].

Bréchard N, Galéa P, Silvy F, Amram M, Chermann JC.

Contracept Fertil Sex. 1997 Sep;25(9):725-9. French.

PMID:
9410396
39.

In vitro study of Seraspenide on HIV-induced inhibition of granulopoiesis.

Coutton C, Chermann JC.

Eur J Haematol. 1997 Sep;59(3):184-9.

PMID:
9310127
40.

[Study of HIV localization in sperm].

Bréchard N, Galéa P, Silvy F, Amram M, Chermann JC.

Contracept Fertil Sex. 1997 May;25(5):389-91. French.

PMID:
9273111
42.

Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progression.

Galea P, Vermot-Desroches C, Le Contel C, Wijdenes J, Chermann JC.

Res Immunol. 1997 Feb;148(2):109-17. Review.

PMID:
9226765
43.

[Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1)].

Machado AA, Hirsch I, Figueiredo JF, Martinez R, de Freitas-Silva G, Chermann JC, Covas DT.

Rev Soc Bras Med Trop. 1996 Nov-Dec;29(6):615-7. Portuguese. No abstract available.

PMID:
9011891
44.

Ocular motor consequences of damage to the abducens nucleus area in humans.

Müri RM, Chermann JF, Cohen L, Rivaud S, Pierrot-Deseilligny C.

J Neuroophthalmol. 1996 Sep;16(3):191-5.

PMID:
8865013
45.

Genetic control of infection of primary macrophages with T-cell-tropic strains of HIV-1.

Hirsch I, de Mareuil J, Salaun D, Chermann JC.

Virology. 1996 May 1;219(1):257-61.

46.

A model allowing the design of modified nucleosides as HIV-RT inhibitors.

Pèpe G, Meyer M, Faury P, Graciet J, Chermann J, Kraus J.

Eur J Med Chem. 1996;31(10):775-86. doi: 10.1016/0223-5234(96)83971-7.

PMID:
22026933
47.

Interface peptides as structure-based human immunodeficiency virus reverse transcriptase inhibitors.

Divita G, Baillon JG, Rittinger K, Chermann JC, Goody RS.

J Biol Chem. 1995 Dec 1;270(48):28642-6.

48.

Fusogenic determinants of highly cytopathic subtype D Zairian isolate HIV-1 NDK.

De Mareuil J, Salaun D, Chermann JC, Hirsch I.

Virology. 1995 Jun 1;209(2):649-53.

49.

HIV Tat protein potentiates in vitro granulomonocytic progenitor cell growth.

Calenda V, Chermann JC.

Eur J Haematol. 1995 Mar;54(3):180-5.

PMID:
7536687
50.

Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside Africa.

Machado AA, Bakpabua M, Salaun D, de Mareuil J, Krchnak V, MacGregor RR, Chermann JC, Hirsch I.

Vaccine. 1995 Feb;13(3):321-5.

PMID:
7631521

Supplemental Content

Loading ...
Support Center